News & Analysis on Clinical Trial Services & Contract Research And Development
Beckman Coulter has launched a gene analysis system that aims to deliver high-throughput, cost effective gene expression via scalable, multiplexed PCR and overcome the biases that limit standard PCR analyses to just a few genes at a time, reports...
According to a recent report, the global bioinformatics market is currently estimated at about $1.4 billion (€1.1 billion). It is expected to grow at an average annual growth rate of 15.8 per cent to reach nearly $3 billion by 2010, reflecting...
Genomic Solutions launches proprietary technology that automates and minitaturises protein crystallisation screening, dispensing both precipitant/mother liquors and protein in volumes ranging from 100 nanolitres to 100 microlitres.
Creo, a Canadian firm which makes imaging and printing technologies, has teamed up with label company Accucote to develop invisibly-tagged, traceable label stocks for the pharmaceutical, medical and other industries, writes Phil Taylor.
Drug delivery specialist SCOLR Pharma has started pilot testing in Canada of a formulation of the osteoporosis drug raloxifene that promises to improve the absorption of the drug and, potentially, hike its efficacy, reports Phil Taylor.
Agilent Technologies is to acquire SSI in a move that will combine the former's analytical instrumentation, data systems and services with SSI's strong position in chromatographic data systems and informatics.
Novartis'collaboration with Myogen looks to have been a shrewd move as Myogen report the extension to the original agreement to include its histone deacetylase inhibitor (HDACi) program. In addition, Myogen has achieved three development milestones...
EaglePicher Pharmaceutical Services and Xcellerex both won awards at a ceremony held last night by market analysis firm Frost & Sullivan.